Skip to content

Omini vs Thrixen

Omini logo

Omini

Multiplex blood testing platform to monitor chronic diseases like heart failure Project co-funded by the European Union

58 employees · est. 2019 · Suresnes, France

VS
Thrixen logo

Thrixen

Unlocking the next generation of simple, affordable & accessible diagnostics

10 employees · est. 2021 · Singapore, Singapore

Omini is the older company (2019 vs 2021); Omini is the larger of the two.

Side-by-Side Comparison

Omini Thrixen
Founded
2019 older 2021
Headquarters
Suresnes, France Singapore, Singapore
Employees
58 larger 10
Industry
Biotechnology, Health Care Biotechnology, Health Care
Funding Stage
Not tracked yet Venture round
Total Funding
$4.39M $7.00M
Funding Rounds
7 1
Services
Decentralized multiplex blood testing platform, Real-time biomarker monitoring, Portable diagnostic solutions, Affordable point-of-care tests Development of multiplex point-of-care diagnostics platform, Bioengineered binder production and licensing, Portable diagnostic device manufacturing, Comprehensive clinical testing solutions
Target Customers
Clinics, Community Healthcare Centers, Pharmacies, Home Healthcare Providers, Hospital-at-Home Programs, Healthcare Professionals Healthcare Providers, Clinical Laboratories, Biotech and Pharma Companies, Research Institutions, Medical Device Distributors
Taxonomy
Biomarker MonitoringPoint-of-care Blood TestingChronic Disease ManagementMultiplex Blood TestingPortable Medical DevicesPersonalized Healthcare +3 BiotechMedtechDiagnostic TechnologyBiomarker DetectionHealthcare MonitoringRapid Diagnostic Test +7
Website
ominilabs.com thrixen.com
Omini logo

About Omini

Omini, founded in 2019 and headquartered in France, is revolutionizing chronic disease management through its groundbreaking technology. The biotechnology company is developing the first point-of-care blood biomarker monitoring platform, a step-change in healthcare solutions aimed at chronic disease...

Thrixen logo

About Thrixen

Thrixen is a biotech/Medtech startup founded in 2021 and based in Singapore. With the slogan "Unlocking the next generation of simple, affordable & accessible diagnostics," Thrixen is dedicated to revolutionizing diagnostic technology for biomarker detection at the chemistry level. The company's aim...

Also comparing in this category

Comparing more than these two?

Get Omini, Thrixen and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Omini compare?

A PDF of Omini and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Omini was founded in 2019, based in Suresnes, France, with 58 employees. Omini, founded in 2019 and headquartered in France, is revolutionizing chronic disease management through its groundbreaking technology. The biotechnology company is developing the first point-of-care. Thrixen was founded in 2021, based in Singapore, Singapore, with 10 employees. Thrixen is a biotech/Medtech startup founded in 2021 and based in Singapore. With the slogan "Unlocking the next generation of simple, affordable & accessible diagnostics," Thrixen is dedicated to rev.
Omini has raised $4.39M and Thrixen $7.00M. Latest stage: Thrixen Venture round.
Both work in Biotechnology and Health Care.

Compare Omini with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Omini on 11 Jun 2025, and Thrixen on 29 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout